Sodium-glucose cotransporter 2 inhibitors and the risk of late onset epilepsy: A real-world cohort study.

The risks of developing dementia and psychiatric disorders were numerically lower among SGLT2i users; however, the reduction in psychiatric disorders did not reach statistical significance, possibly reflecting limited statistical power to detect modest associations given the small sample size.

also in 111,027 other papers